StonvexLoading…
StonvexStonvexStonvexCore line items from NTAP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-04-25 | Annual 2024 2024-04-26 | Annual 2023 2023-04-28 | Annual 2022 2022-04-29 |
|---|---|---|---|---|
Revenue | $6.57B | $6.27B | $6.36B | $6.32B |
Operating Income | $1.34B | $1.21B | $1.02B | $1.16B |
Net Income | $1.19B | $986.00M | $1.27B | $937.00M |
EPS (Diluted) | $5.67 | $4.63 | $5.79 | $4.09 |
Total Assets | $10.82B | $9.89B | $9.82B | $10.03B |
Total Liabilities | $9.78B | $8.74B | $8.66B | $9.19B |
Cash & Equivalents | $2.74B | $1.90B | $2.32B | $4.11B |
Free Cash Flow OCF − CapEx | $1.34B | $1.53B | $868.00M | $985.00M |
Shares Outstanding | 201.00M | 206.00M | 212.00M | 220.00M |